<![CDATA[C2N Diagnostics, LLC 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=45114>Tue, 21 Apr 2026 11:18:51 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[C2N Diagnostics Enters South Korean Market Through Partnership with BeauBrain Healthcare to Offer Precivity™ Portfolio of Blood Tests to Help Doctors Diagnose Alzheimer’s Disease]]>https://www.newswire.co.kr/newsRead.php?no=1030278Fri, 13 Mar 2026 15:55:00 +0900<![CDATA[C2N 다이어그노스틱스, 뷰브레인 헬스케어와 파트너십 통해 한국 시장 진출… 알츠하이머병 진단 돕는 프리시비티 혈액 검사 포트폴리오 제공]]>https://www.newswire.co.kr/newsRead.php?no=1030279Fri, 13 Mar 2026 15:55:00 +0900<![CDATA[C₂N Diagnostics, LLC Announces Investment From Eisai Inc.]]>https://www.newswire.co.kr/newsRead.php?no=985523Thu, 07 Mar 2024 14:30:00 +0900<![CDATA[C₂N 다이어그노스틱스, 에이사의의 투자 발표]]>https://www.newswire.co.kr/newsRead.php?no=985525Thu, 07 Mar 2024 14:30:00 +0900